| References |
Top |
| REF 1 |
Histone deacetylase interacts directly with DNA topoisomerase II. Nat Genet. 2000 Nov;26(3):349-53.
|
| REF 2 |
Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis. J Biol Chem. 2001 Feb 16;276(7):4539-42.
|
| REF 3 |
A census of human soluble protein complexes. Cell. 2012 Aug 31;150(5):1068-81.
|
| REF 4 |
Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8288-93.
|
| REF 5 |
A bead-based approach for large-scale identification of in vitro kinase substrates. Proteomics. 2011 Dec;11(24):4632-7.
|
| REF 6 |
Panorama of ancient metazoan macromolecular complexes. Nature. 2015 Sep 17;525(7569):339-44.
|
| REF 7 |
Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase II degradation in hepatocellular carcinoma cells. Hepatology. 2011 Jan;53(1):148-59.
|
| REF 8 |
Interaction between glucose-regulated destruction domain of DNA topoisomerase IIalpha and MPN domain of Jab1/CSN5. J Biol Chem. 2004 Jul 23;279(30):31296-303.
|
| REF 9 |
Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. Gastroenterology. 2005 Oct;129(4):1225-36.
|
